Inteliquet

Inteliquet operates at the intersection of oncology, digital health, and AI, providing a software-as-a-service (SaaS) platform to streamline the complex process of clinical trial matching. The company's core value proposition is using structured real-world data from electronic health records (EHRs) and other sources to intelligently identify and pre-screen eligible patients for oncology trials, thereby reducing enrollment times and costs for trial sponsors. As a private company founded in 2015, it targets a significant pain point in drug development, positioning itself as an enabler for more efficient and inclusive clinical research. Its success hinges on data partnerships, algorithm accuracy, and adoption by major biopharma and research institutions.

AI/ML-powered platform that uses structured real-world data (RWD) from electronic health records to match oncology patients with appropriate clinical trials, optimizing patient pre-screening and enrollment.

Inteliquet competes in the clinical trial matching and patient recruitment enablement space. Competitors include other digital health startups (e.g., Deep 6 AI, TriNetX), large contract research organizations (CROs) developing internal tech, and electronic health record (EHR) companies adding trial matching modules. Differentiation is based on data network size, algorithm accuracy, and oncology-specific focus.